Literature DB >> 31361008

FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology.

Qinwen Mao1, Xiaojing Zheng2, Tamar Gefen3, Emily Rogalski3, Callen L Spencer3, Rosa Rademakers4, Angela J Fought5, Missia Kohler6, Sandra Weintraub3, Haibin Xia2, Marek-Marsel Mesulam3, Eileen H Bigio1,3.   

Abstract

Heterozygous loss-of-function mutations in the GRN gene lead to progranulin (PGRN) haploinsufficiency and cause frontotemporal lobar degeneration with TDP-43 pathology type A (FTLD-TDP type A). PGRN is a highly conserved, secreted glycoprotein and functions in the central nervous system as a key modulator of microglial function. Hence, altered microglial function caused by PGRN deficiency may be tied to the pathogenesis of FTLD-TDP. Our previous studies showed that haploinsufficiency of GRN mutations extends to microglial PGRN expression in the hippocampal CA1 region. In this study, we found that the CA1 sector was associated with less neuronal loss and more frequent TDP-43 inclusions in FTLD-TDP type A cases with GRN mutations than in sporadic cases. In addition, the CA1 region in GRN mutation cases contained more rod-like microglia, which also had reduced PGRN expression. These findings suggest that the profile of TDP-43 inclusions, neuronal number, and microgliosis in the CA1 sector of FTLD-TDP type A cases may be influenced by GRN gene expression status.
© 2019 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Frontotemporal lobar degeneration; Hippocampal sclerosis; Microglia; Neuroinflammation; Progranulin; TAR DNA-binding protein 43

Mesh:

Substances:

Year:  2019        PMID: 31361008      PMCID: PMC7967835          DOI: 10.1093/jnen/nlz059

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  54 in total

1.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.

Authors:  Thomas J Montine; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; John Q Trojanowski; Harry V Vinters; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2011-11-20       Impact factor: 17.088

Review 2.  Changing face of microglia.

Authors:  Manuel B Graeber
Journal:  Science       Date:  2010-11-05       Impact factor: 47.728

3.  TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.

Authors:  Manuela Neumann; Ian R Mackenzie; Nigel J Cairns; Philip J Boyer; William R Markesbery; Charles D Smith; J Paul Taylor; Hans A Kretzschmar; Virginia E Kimonis; Mark S Forman
Journal:  J Neuropathol Exp Neurol       Date:  2007-02       Impact factor: 3.685

4.  Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields.

Authors:  Kimmo J Hatanpaa; Jack M Raisanen; Emily Herndon; Dennis K Burns; Chan Foong; Amyn A Habib; Charles L White
Journal:  J Neuropathol Exp Neurol       Date:  2014-02       Impact factor: 3.685

5.  Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration.

Authors:  Keith A Josephs; Dennis W Dickson
Journal:  Neurobiol Aging       Date:  2006-08-22       Impact factor: 4.673

6.  Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.

Authors:  Nigel J Cairns; Eileen H Bigio; Ian R A Mackenzie; Manuela Neumann; Virginia M-Y Lee; Kimmo J Hatanpaa; Charles L White; Julie A Schneider; Lea Tenenholz Grinberg; Glenda Halliday; Charles Duyckaerts; James S Lowe; Ida E Holm; Markus Tolnay; Koichi Okamoto; Hideaki Yokoo; Shigeo Murayama; John Woulfe; David G Munoz; Dennis W Dickson; Paul G Ince; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2007-06-20       Impact factor: 17.088

7.  Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia.

Authors:  D S Knopman; A R Mastri; W H Frey; J H Sung; T Rustan
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

8.  Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.

Authors:  Jennifer Gass; Ashley Cannon; Ian R Mackenzie; Bradley Boeve; Matt Baker; Jennifer Adamson; Richard Crook; Stacey Melquist; Karen Kuntz; Ron Petersen; Keith Josephs; Stuart M Pickering-Brown; Neill Graff-Radford; Ryan Uitti; Dennis Dickson; Zbigniew Wszolek; John Gonzalez; Thomas G Beach; Eileen Bigio; Nancy Johnson; Sandra Weintraub; Marsel Mesulam; Charles L White; Bryan Woodruff; Richard Caselli; Ging-Yuek Hsiung; Howard Feldman; Dave Knopman; Mike Hutton; Rosa Rademakers
Journal:  Hum Mol Genet       Date:  2006-09-01       Impact factor: 6.150

9.  Progranulin regulates neuronal outgrowth independent of sortilin.

Authors:  Jennifer Gass; Wing C Lee; Casey Cook; Nicole Finch; Caroline Stetler; Karen Jansen-West; Jada Lewis; Christopher D Link; Rosa Rademakers; Anders Nykjær; Leonard Petrucelli
Journal:  Mol Neurodegener       Date:  2012-07-10       Impact factor: 14.195

10.  Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype.

Authors:  Ian R A Mackenzie; Atik Baborie; Stuart Pickering-Brown; Daniel Du Plessis; Evelyn Jaros; Robert H Perry; David Neary; Julie S Snowden; David M A Mann
Journal:  Acta Neuropathol       Date:  2006-09-26       Impact factor: 17.088

View more
  6 in total

1.  Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.

Authors:  Xiaolai Zhou; Thomas Kukar; Rosa Rademakers
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Differential neuropathology and functional outcome after equivalent traumatic brain injury in aged versus young adult mice.

Authors:  Mecca B A R Islam; Booker T Davis; Mary J Kando; Qinwen Mao; Daniele Procissi; Craig Weiss; Steven J Schwulst
Journal:  Exp Neurol       Date:  2021-04-05       Impact factor: 5.620

Review 3.  An update on the rod microglia variant in experimental and clinical brain injury and disease.

Authors:  Katherine R Giordano; Charlotte R Denman; Phoebe S Dubisch; Murtaza Akhter; Jonathan Lifshitz
Journal:  Brain Commun       Date:  2021-01-04

4.  Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer Disease.

Authors:  Anarmaa Mendsaikhan; Ikuo Tooyama; Geidy E Serrano; Thomas G Beach; Douglas G Walker
Journal:  J Neuropathol Exp Neurol       Date:  2021-09-10       Impact factor: 3.148

5.  Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration.

Authors:  Ione O C Woollacott; Christina E Toomey; Catherine Strand; Robert Courtney; Bridget C Benson; Jonathan D Rohrer; Tammaryn Lashley
Journal:  J Neuroinflammation       Date:  2020-08-10       Impact factor: 8.322

6.  Novel TUBA4A Variant Associated With Familial Frontotemporal Dementia.

Authors:  Merel O Mol; Tsz H Wong; Shamiram Melhem; Sreya Basu; Riccardo Viscusi; Niels Galjart; Annemieke J M Rozemuller; Claudia Fallini; John E Landers; Laura Donker Kaat; Harro Seelaar; Jeroen G J van Rooij; John C van Swieten
Journal:  Neurol Genet       Date:  2021-05-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.